Navegando por Assunto "Edaravona"

Agora exibindo 1 - 3 de 3

Acesso aberto (Open Access)
Atividade antiinflamatória e neuroprotetora da Edaravona no córtex sensóriomotor primário de ratos adultos submetidos à isquemia focal experimental
(Universidade Federal do Pará, 2014-02-12) ARAÚJO, Sanderson Corrêa; BORGES, Rosivaldo dos Santos; http://lattes.cnpq.br/4783661132100859; LEAL, Walace Gomes; http://lattes.cnpq.br/2085871005197072
Stroke is a neural disorder originated from blood flow decreasing or interruption, making inadequate energy supply in the region, thus promoting tissue damage. The stroke can be divided in hemorragic or ischemic. The ischemic stroke is more prevalent and can occur through thrombosis or embolism. The ischemic pathology has multiple interrelated events like excitotoxicity, peri-infarct depolarization, oxidative and nitrosative stress, inflammation and apoptosis. An element of fundamental importance in ischemic pathology is the microglial cell, whose activity is closely linked to the progression of environment harm. A therapeutic alternative in the treatment of stroke is a pyrazolone called Edaravone. This study evaluated the neuroprotective effect of Edaravone dose of 3mg/kg in primary sensorymotor cortex after focal ischemic lesion. Edaravone treated animals (N = 10) and animals treated with saline solution (N = 10) in the survival time of 1 and 7 days after the ischemic event was evaluated. Treatment whith edaravone showed by histopathological analysis with cresyl violet a reduction of 49% and 66% in infarct size in animals in survival time 1 and 7 days respectively. Immunohistochemistry studies for microglia/macrophages assets (ED1+) demonstrated a reduction in the presence of ED1+ cells in 35% and 41% survival times for 1 and 7 days, respectively. Neutrophils (MBS-1+) were reduced to 64% only in animals with survival times a day. Harmful patterns were assessed qualitatively and quantitatively. Data was tested by ANOVA with Tukey post hoc test. Differences were considered significant at p < 0,05.
Acesso aberto (Open Access)
Planejamento de novos derivados da Edaravona
(Universidade Federal do Pará, 2009-06-30) QUEIROZ, Auriekson Noronha; BORGES, Rosivaldo dos Santos; http://lattes.cnpq.br/4783661132100859
A detailed theoretical study of the edaravone was carried out by DFT method using B3LYP/6-31G* basis set, with the objective to clarify the scavenging mechanism and influence of edaravone tautomerism under acid condition, which will be helpful to elucidate the radical-scavenging mechanisms in the ischemic process. Previous theoretical studies, tautomerization, solvent effects, and electron abstraction no were considered. In this work, the stability and reactivity were determined through geometric and energetic parameters were realized in gas phase and PCM methods in water and methanol. The acid or basic conditions were considered by bond dissociation or protonation energies may undergo anion or cation products, respectively. The antioxidant properties were calculated through HOMO, ionization potential (IP), and bond dissociation energies (BDE). HOMO and IP values showed that N-H tautomer is better antioxidant by electron abstraction, while BDE values showed that O-H tautomer is better antioxidant by hydrogen abstraction. The protonation is thermodynamically more favored than deprotonation. Furthermore, the protonation energy explain, theoretical, the reduced difference between N and O protonation. The protonation is thermodynamically more favored than deprotonation. The solvent effect decreased energies barriers to isomerization in O-H or N-H tautomers. In addition, three pyrazolone derivatives were evaluated its antioxidant activities comparated to edaravone, in an effort to develop the evaluated and pharmacophore antioxidant identification. The antioxidant activity of antypirine, dypirone, phenylbuthazone and edaravone was determined measuring the inhibition of two stables free radical DPPH and ABTS. Edaravone and phenylbuthazone exhibited more potent inhibition of DPPH and ABTS radical scavenging than dypirone, while antypirine not shown activity in all concentrations analyzed. Simultaneously, the DFT method can provide an antioxidant potential value to explain the structure-activity relationship (SAR). Furthermore, was evaluated their antioxidant activities and the ionization potential, HOMO, BDE X-H, and stabilization energies (DEiso) of the compounds have been calculated using the density functional theory (DFT) method at the B3LYP level, employing the 6-31G(d) basis set, to explore the SAR. All calculations have been performed by using the Gaussian 03 program, Hyperchem 7.5, and ChemOffice 2005. The results showed that derivatives with C-H in 4-position increased electron or hydrogen abstraction. Finality, the general strategy employed to design the target compounds was based on the studies of eighteen derivatives of edaravone. The SAR studies supported the three groups, such as more active, active and less active. Nine compounds were design with successful based in the structure of more active.
Acesso aberto (Open Access)
Planejamento, síntese e avaliação dos derivados da edaravona quanto à atividade antioxidante
(Universidade Federal do Pará, 2018-03-28) AIRES, Wanessa Castilho; OLIVEIRA, Karen Renata Matos; http://lattes.cnpq.br/3032008039259369; BORGES, Rosivaldo dos Santos; http://lattes.cnpq.br/4783661132100859; https://orcid.org/ 0000-0003-4072-7573
Edaravone is a commercial drug released on the Japanese Market, indicated in the treatment and prevention of ischemic stroke. Its action is due to its scavenger properties of free radical released in the ischemia. However, its use may lead to a kidney toxic effect. Therefore, in this work, a new bioisostere derivative from Edaravone was proposed, by the change of a pyrazolone ring for an indolone. Antioxidant properties was determined through computational methods. Calculations were undertaken in the software Gaussian, through the B3LYP method, with the set of bases 6-31G (d, p). Antioxidant activity was predicted from HOMO, LUMO, Gap, Ionization potential (IP) and Bond dissociation energy (BDE). Results indicate analogous compounds showed higher ClogP values compared to Edaravone, which means higher facility to pass through biological barriers, with higher liposoluble properties. Edaravone derivative, called Imidazone, also showed higher antioxidant potential than Edaravone. Methyl group in second position of heterocyclic ring was essential to more stable resonance structures formation to semiquinone form. All new derivatives proposed were extremely promising with antioxidant capacity superior to Edaravone.